BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32079521)

  • 1. Modeling of the Enzyme-Substrate Complexes of Human Poly(ADP-Ribose) Polymerase 1.
    Nilov DK; Pushkarev SV; Gushchina IV; Manasaryan GA; Kirsanov KI; Švedas VK
    Biochemistry (Mosc); 2020 Jan; 85(1):99-107. PubMed ID: 32079521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Mechanisms of PARP-1 Inhibitor 7-Methylguanine.
    Nilov D; Maluchenko N; Kurgina T; Pushkarev S; Lys A; Kutuzov M; Gerasimova N; Feofanov A; Švedas V; Lavrik O; Studitsky VM
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32245127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generating Protein-Linked and Protein-Free Mono-, Oligo-, and Poly(ADP-Ribose) In Vitro.
    Lin KY; Huang D; Kraus WL
    Methods Mol Biol; 2018; 1813():91-108. PubMed ID: 30097863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of disaccharide nucleoside analogues as potential poly(ADP-ribose) polymerase-1 inhibitors.
    Zheng M; Mex M; Götz KH; Marx A
    Org Biomol Chem; 2018 Nov; 16(46):8904-8907. PubMed ID: 30203829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design of new poly (ADP-ribose) polymerase (PARP-1) inhibitors.
    Chadha N; Jaggi AS; Silakari O
    Mol Divers; 2017 Aug; 21(3):655-660. PubMed ID: 28653128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2,5-Diketopiperazines: A New Class of Poly(ADP-ribose)polymerase Inhibitors.
    Nilov DK; Yashina KI; Gushchina IV; Zakharenko AL; Sukhanova MV; Lavrik OI; Švedas VK
    Biochemistry (Mosc); 2018 Feb; 83(2):152-158. PubMed ID: 29618301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of PARP-1 activity based on hyperbranched-poly (ADP-ribose) polymers responsive current in artificial nanochannels.
    Liu Y; Fan J; Yang H; Xu E; Wei W; Zhang Y; Liu S
    Biosens Bioelectron; 2018 Aug; 113():136-141. PubMed ID: 29754052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple receptor conformation docking, dock pose clustering and 3D QSAR studies on human poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors.
    Fatima S; Jatavath MB; Bathini R; Sivan SK; Manga V
    J Recept Signal Transduct Res; 2014 Oct; 34(5):417-30. PubMed ID: 25046176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ADP-ribose)--a unique natural polymer structural features, biological role and approaches to the chemical synthesis.
    Drenichev MS; Mikhailov SN
    Nucleosides Nucleotides Nucleic Acids; 2015; 34(4):258-76. PubMed ID: 25774719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure based pharmacophore study to identify possible natural selective PARP-1 trapper as anti-cancer agent.
    Kumar C; P T V L; Arunachalam A
    Comput Biol Chem; 2019 Jun; 80():314-323. PubMed ID: 31078910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and Biophysical Assays of PAR-WWE Domain Interactions and Production of iso-ADPr for PAR-Binding Analysis.
    Wang Z; Xu W
    Methods Mol Biol; 2018; 1813():65-73. PubMed ID: 30097861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissection of ADP-ribose polymer synthesis into individual steps of initiation, elongation, and branching.
    Alvarez-Gonzalez R; Mendoza-Alvarez H
    Biochimie; 1995; 77(6):403-7. PubMed ID: 7578422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.
    Alemasova EE; Lavrik OI
    Nucleic Acids Res; 2019 May; 47(8):3811-3827. PubMed ID: 30799503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the enzymatic catalysis of poly(ADP-ribose) polymerase by dsDNA, polyamines, Mg2+, Ca2+, histones H1 and H3, and ATP.
    Kun E; Kirsten E; Mendeleyev J; Ordahl CP
    Biochemistry; 2004 Jan; 43(1):210-6. PubMed ID: 14705947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Throughput Colorimetric Assay for Identifying PARP-1 Inhibitors Using a Large Small-Molecule Collection.
    Kotova E; Tulin AV
    Methods Mol Biol; 2017; 1608():299-312. PubMed ID: 28695517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis and Molecular Modeling Study of Conjugates of ADP and Morpholino Nucleosides as A Novel Class of Inhibitors of PARP-1, PARP-2 and PARP-3.
    Sherstyuk YV; Ivanisenko NV; Zakharenko AL; Sukhanova MV; Peshkov RY; Eltsov IV; Kutuzov MM; Kurgina TA; Belousova EA; Ivanisenko VA; Lavrik OI; Silnikov VN; Abramova TV
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31892271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasensitive electrochemical detection of poly (ADP-ribose) polymerase-1 via polyaniline deposition.
    Liu Y; Fan J; Shangguan L; Liu Y; Wei Y; Wei W; Liu S
    Talanta; 2018 Apr; 180():127-132. PubMed ID: 29332790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting sirtuin and poly(ADP-ribose)polymerase activities of selected 2,4,6-trisubstituted benzimidazoles.
    Yeong KY; Tan SC; Mai CW; Leong CO; Chung FF; Lee YK; Chee CF; Abdul Rahman N
    Chem Biol Drug Des; 2018 Jan; 91(1):213-219. PubMed ID: 28719017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking and Biological Evaluation for Identification of Potential Poly (ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors.
    Zhou Y; Tang S; Chen T; Niu MM
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31766720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ADP-ribosylation) and genomic stability.
    Oei SL; Keil C; Ziegler M
    Biochem Cell Biol; 2005 Jun; 83(3):263-9. PubMed ID: 15959554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.